Structural differences of neutrophil extracellular traps induced by biochemical and microbiologic stimuli under healthy and autoimmune milieus.
Sorely Adelina Sosa-LuisWilliam de Jesús Ríos-RíosÁngeles Esmeralda Gómez-BustamanteMaría de Los Ángeles Romero-TlaloliniAguilar-Ruiz Sergio RobertoRafael Baltierez-HoyosTorres-Aguilar HonorioPublished in: Immunologic research (2021)
Neutrophil extracellular traps (NETs) are networks of decondensed chromatin loaded with antimicrobial peptides and enzymes produced against microorganisms or biochemical stimuli. Since their discovery, numerous studies made separately have revealed multiple triggers that induce similar NET morphologies allowing to classify them as lytic or non-lytic. However, the variability in NET composition depending on the inducer agent and the local milieu under similar conditions has been scarcely studied. In this work, a comparative study was conducted to evaluate structural and enzymatic divergences in NET composition induced by biochemical (phorbol myristate acetate [PMA] and hypochlorous acid [HOCl]) and microbiologic (Candida albicans, Staphylococcus aureus, and Pseudomonas aeruginosa) stimuli, along with the presence of plasma from healthy donors or patients with systemic lupus erythematosus (SLE). The results showed a differential composition of DNA and the antimicrobial peptide cathelicidin (LL37) and a variable enzymatic activity (neutrophil elastase, cathepsin G, myeloperoxidase) induced by the different stimuli despite showing morphologically similar NETs. Additionally, SLE plasma´s presence increased DNA and LL37 release during NET induction independently of the trigger stimulus but with no enzymatic activity differences. This work provides new evidence about NET composition variability depending on the inducer stimulus and the local milieu.
Keyphrases
- candida albicans
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- systemic lupus erythematosus
- hydrogen peroxide
- circulating tumor
- single molecule
- cell free
- cystic fibrosis
- small molecule
- disease activity
- gene expression
- drug delivery
- multiple sclerosis
- high throughput
- single cell
- rheumatoid arthritis
- genome wide
- dna methylation
- cancer therapy
- fluorescent probe
- circulating tumor cells